Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002724674 | SCV003734381 | uncertain significance | Inborn genetic diseases | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.3220G>A (p.D1074N) alteration is located in exon 28 (coding exon 28) of the ANK1 gene. This alteration results from a G to A substitution at nucleotide position 3220, causing the aspartic acid (D) at amino acid position 1074 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003491302 | SCV004234202 | uncertain significance | Hereditary spherocytosis type 1 | 2023-06-06 | criteria provided, single submitter | clinical testing |